Quillichew Er Tablet, Chewable, Extended Release
Product Images NDC 24478-075

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quillichew Er (NDC 24478-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nextwave Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quillichew Er 1

Chemical structure of methylphenidate hydrochloride, the active ingredient in QuilliChew ER. The structure shows the molecular formula C14H19NO2·HCl and the molecular weight of 269.77.*

FDA Label Image

Quillichew Er 2

A pharmacokinetic line graph showing mean plasma concentrations of methylphenidate over 24 hours. It compares QuilliChew ER 40 mg (solid line) and Methylphenidate IRCT 40 mg (two equal doses 6 hours apart, dotted line), with plasma concentration (ng/mL) on the y-axis and time (hours) on the x-axis.*

FDA Label Image

Quillichew Er 3

A line graph comparing LS Mean SKAMP-Combined Scores over 13 hours post-dose between QuilliChew ER and placebo groups. The x-axis represents hours post-dose (0 to 13), and the y-axis shows scores (0 to 25). QuilliChew ER scores decrease initially then increase over time, while placebo scores remain relatively stable.*

FDA Label Image

Quillichew Er 4

FDA Label Image

Quillichew Er 5

FDA Label Image

Quillichew Er 6

Label for QuilliChew ER 20 mg extended-release chewable tablets, containing methylphenidate hydrochloride. The label includes storage instructions (20°C to 25°C), dosage and use notes, and a warning to keep out of reach of children. It states that each scored tablet contains 20 mg methylphenidate HCl and approximately 3 mg phenylalanine. The label displays the distributor, NextWave Pharmaceuticals, Inc., and manufacturer, Tris Pharma, Inc., along with a package size of 100 tablets and Rx only status.*

FDA Label Image

Quillichew Er 7

The packaging label for QuilliChew ER 30 mg extended-release chewable tablets featuring methylphenidate hydrochloride. The label includes storage instructions, dosage details, a barcode, and manufacturer information for Tris Pharma, Inc., distributed by NextWave Pharmaceuticals, Inc. It also notes the package contains 100 tablets and emphasizes pharmacist dispensing guidelines.*

FDA Label Image

Quillichew Er 8

Label for QuilliChew ER 40 mg extended-release chewable tablets containing methylphenidate hydrochloride. The label includes storage instructions, dosage warnings, and states the product is distributed by NextWave Pharmaceuticals, Inc. and manufactured by Tris Pharma, Inc. The package contains 100 tablets for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.